Evidence map›Paper›PMID 32596109›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2020

Size-Dependent Pulmonary Impact of Thin Graphene Oxide Sheets in Mice: Toward Safe-by-Design.

Artur Filipe Rodrigues, Leon Newman, Dhifaf Jasim, Sourav P Mukherjee, Jun Wang, Isabella A Vacchi, Cécilia Ménard-Moyon, Alberto Bianco, Bengt Fadeel, Kostas Kostarelos and 1 more

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 69 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Advances in 2D materials for wearable biomonitoring.Materials science & engineering. R, Reports : a review journal · 2025
    Article
  5. Article
  6. Safety Assessment of Graphene-Based Materials.Small (Weinheim an der Bergstrasse, Germany) · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 4 countries.

Artur Filipe RodriguesNanomedicine Lab Faculty of Biology, Medicine and Health University of Manchester Manchester Academic Health Science Centre Manchester M13 9PT UK.
Leon NewmanNanomedicine Lab Faculty of Biology, Medicine and Health University of Manchester Manchester Academic Health Science Centre Manchester M13 9PT UK.
Dhifaf JasimNanomedicine Lab Faculty of Biology, Medicine and Health University of Manchester Manchester Academic Health Science Centre Manchester M13 9PT UK.
Sourav P MukherjeeNanosafety & Nanomedicine Laboratory Institute of Environmental Medicine Karolinska Institutet Stockholm 171 77 Sweden.
Jun WangScience for Life Laboratory Department of Biochemistry and Biophysics Stockholm University Stockholm 171 65 Sweden.
Isabella A VacchiUniversity of Strasbourg CNRS Immunology, Immunopathology and Therapeutic Chemistry UPR 3572 Strasbourg 67 084 France.
Cécilia Ménard-MoyonUniversity of Strasbourg CNRS Immunology, Immunopathology and Therapeutic Chemistry UPR 3572 Strasbourg 67 084 France.
Alberto BiancoUniversity of Strasbourg CNRS Immunology, Immunopathology and Therapeutic Chemistry UPR 3572 Strasbourg 67 084 France.
Bengt FadeelNanosafety & Nanomedicine Laboratory Institute of Environmental Medicine Karolinska Institutet Stockholm 171 77 Sweden.
Kostas KostarelosNanomedicine Lab Faculty of Biology, Medicine and Health University of Manchester Manchester Academic Health Science Centre Manchester M13 9PT UK.
Cyrill BussyNanomedicine Lab Faculty of Biology, Medicine and Health University of Manchester Manchester Academic Health Science Centre Manchester M13 9PT UK.ORCID https://orcid.org/0000-0001-8870-443X
Manchester Academic Health Science Centre · GBCentre National de la Recherche Scientifique · FRKarolinska Institutet · SEStockholm University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Safety assessment of graphene-based materials (GBMs) including graphene oxide (GO) is essential for their safe use across many sectors of society. In particular, the link between specific material properties and biological effects needs to be further elucidated. Here, the effects of lateral dimensions of GO sheets in acute and chronic pulmonary responses after single intranasal instillation in mice are compared. Micrometer-sized GO induces stronger pulmonary inflammation than nanometer-sized GO, despite reduced translocation to the lungs. Genome-wide RNA sequencing also reveals distinct size-dependent effects of GO, in agreement with the histopathological results. Although large GO, but not the smallest GO, triggers the formation of granulomas that persists for up to 90 days, no pulmonary fibrosis is observed. These latter results can be partly explained by Raman imaging, which evidences the progressive biotransformation of GO into less graphitic structures. The findings demonstrate that lateral dimensions play a fundamental role in the pulmonary response to GO, and suggest that airborne exposure to micrometer-sized GO should be avoided in the production plant or applications, where aerosolized dispersions are likely to occur. These results are important toward the implementation of a safer-by-design approach for GBM products and applications, for the benefit of workers and end-users.

Indexed as

graphene oxideinflammationlungmacrophagesmiceRNA sequencing

Identifiers

PMID32596109
PMCPMC7312279
OpenAlexW3016135707

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.